These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1583873)

  • 1. Animal models for lysosomal storage diseases: a new case of feline mucopolysaccharidosis VI.
    Di Natale P; Annella T; Daniele A; Spagnuolo G; Cerundolo R; de Caprariis D; Gravino AE
    J Inherit Metab Dis; 1992; 15(1):17-24. PubMed ID: 1583873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary molecular analysis of a case of feline mucopolysaccharidosis VI.
    De Luca T; Minichiello L; Leone A; Di Natale P
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1177-82. PubMed ID: 7504466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.
    Jezyk PF; Haskins ME; Patterson DF; Mellman WJ; Greenstein M
    Science; 1977 Nov; 198(4319):834-6. PubMed ID: 144321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype.
    Tønnesen T; Gregersen HN; Güttler F
    J Med Genet; 1991 Jul; 28(7):499-501. PubMed ID: 1832719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The early diagnosis of Maroteaux-Lamy syndrome with confirmation of arylsulphatase deficiency].
    Van Biervliet JP; Van Leeuwen EF; Abeling NG; De Jonge HF; Liem KO; Wadman SK
    Arch Fr Pediatr; 1977 Apr; 34(4):362-70. PubMed ID: 142458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylsulphatase B (Maroteaux-Lamy factor): a part of the enzyme system responsible for sulphate release from mucopolysaccharide fragment.
    Gniot-Szulzycka J; Donnelly PV
    FEBS Lett; 1976 May; 65(1):63-8. PubMed ID: 819304
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathological characteristics of mucopolysaccharidosis VI in the rat.
    Yoshida M; Ikadai H; Maekawa A; Takahashi M; Nagase S
    J Comp Pathol; 1993 Aug; 109(2):141-53. PubMed ID: 8245230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.
    Evers M; Saftig P; Schmidt P; Hafner A; McLoghlin DB; Schmahl W; Hess B; von Figura K; Peters C
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8214-9. PubMed ID: 8710849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathology of the feline model of mucopolysaccharidosis VI.
    Haskins ME; Aguirre GD; Jezyk PF; Patterson DF
    Am J Pathol; 1980 Dec; 101(3):657-74. PubMed ID: 6778219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal and prenatal diagnosis of Maroteaux-Lamy syndrome.
    Rogoyski A; Czartoryska B; Kleijer WJ; Niermeijer MF; Tronowska TD; Gorska D; Polatynska-Krzyspiak B; Zaremba J
    Acta Anthropogenet; 1985; 9(1-3):109-16. PubMed ID: 3939668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1.
    Jackson CE; Yuhki N; Desnick RJ; Haskins ME; O'Brien SJ; Schuchman EH
    Genomics; 1992 Oct; 14(2):403-11. PubMed ID: 1427856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylsulfatase B-deficient mucopolysaccharidosis in rats.
    Yoshida M; Noguchi J; Ikadai H; Takahashi M; Nagase S
    J Clin Invest; 1993 Mar; 91(3):1099-104. PubMed ID: 8450039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental retardation in a patient with Maroteaux-Lamy.
    Vestermark S; Tønnesen T; Andersen MS; Güttler F
    Clin Genet; 1987 Feb; 31(2):114-7. PubMed ID: 3103957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis VI in a Siamese/short-haired European cat.
    Macrì B; Marino F; Mazzullo G; Trusso A; De Maria R; Amedeo S; Divari S; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2002 Oct; 49(8):438-42. PubMed ID: 12450194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.
    Crawley AC; Brooks DA; Muller VJ; Petersen BA; Isaac EL; Bielicki J; King BM; Boulter CD; Moore AJ; Fazzalari NL; Anson DS; Byers S; Hopwood JJ
    J Clin Invest; 1996 Apr; 97(8):1864-73. PubMed ID: 8621770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal model studies of allelism: characterization of arylsulfatase B mutations in homoallelic and heteroallelic (genetic compound) homozygotes with feline mucopolysaccharidosis VI.
    McGovern MM; Mandell N; Haskins M; Desnick RJ
    Genetics; 1985 Aug; 110(4):733-49. PubMed ID: 3928430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
    J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI.
    Byers S; Nuttall JD; Crawley AC; Hopwood JJ; Smith K; Fazzalari NL
    Bone; 1997 Nov; 21(5):425-31. PubMed ID: 9356736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
    Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
    Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.